Mr. Richard Corbridge:

I thank the Chairman. First, on funding and the size of funding, the team size, that is, the people on the team probably is the area we must consider most in 2017. We are spending money from a capital point of view that allows us to buy technology. Our biggest problem is having people to implement and, in particular, with people working with Ms Yvonne Goff's team to do the business change part of it. It is all well and good to have enough money to buy the brown boxes and cables and to put them into hospitals but we need additional resources to train people and make the business change happen. There is a real risk in information technology across the world and in health care in particular of spending money on technology that people cannot use. This is a major pattern that was seen in the United States and is why we have concentrated in 2015 and 2016 in particular on making sure that the clinical engagement, namely, the 200 people working with Ms Goff, bring to bear that resource, which is different, on how we actually implement in that space. My suggestion or request would be that consideration be given less to the capital budget and changes therein and more to the revenue side. IT in general is moving more towards a platform as a service, that is, things as a service one buys each year, rather than as an investment that lasts for five or ten years. One point to bear in mind with technology and the investment thus far is that in Ireland today, there are patient administration systems in hospitals in Dublin that are 32 years old. That kind of investment has not happened and therefore driving that forward would be a useful way to go. Would Ms Goff like to say anything about the ePharmacy piece?